Cahill Thomas
Insider CIK 1922939 · PRME Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRME Prime Medicine, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 45,000 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | D To issuer deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-08-01 | 2025-08-05 | 39,062 | — | $0 | 39,062 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PRME Prime Medicine, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 39,062 | — | $0 | 39,062 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 9,999,999 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 5,250,781 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 5,305,679 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 4,905,679 | — | $0 | 4,905,679 | SEC↗ |